BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15230496)

  • 1. Lower costs of hospital treatment of breast cancer through a population-based mammography screening programme.
    Kauhava L; Immonen-Räihä P; Parvinen I; Helenius H; Kaljonen A; Räsänen O; Pylkkänen L; Klemi PJ
    Eur J Public Health; 2004 Jun; 14(2):128-33. PubMed ID: 15230496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based mammography screening results in substantial savings in treatment costs for fatal breast cancer.
    Kauhava L; Immonen-Räihä P; Parvinen I; Holli K; Kronqvist P; Pylkkänen L; Helenius H; Kaljonen A; Räsänen O; Klemi PJ
    Breast Cancer Res Treat; 2006 Jul; 98(2):143-50. PubMed ID: 16538536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
    Zahl PH; Gøtzsche PC; Mæhlen J
    Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
    Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
    Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expected 10-year treatment cost of breast cancer detected within and outside a public screening program in Norway.
    Moger TA; Bjørnelv GM; Aas E
    Eur J Health Econ; 2016 Jul; 17(6):745-54. PubMed ID: 26239280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammography screening: an incremental cost effectiveness analysis of two view versus one view procedures in London.
    Bryan S; Brown J; Warren R
    J Epidemiol Community Health; 1995 Feb; 49(1):70-8. PubMed ID: 7707010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
    Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
    Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
    van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
    Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of invasive breast cancers detected by screening mammography.
    Zahl PH; Maehlen J; Welch HG
    Arch Intern Med; 2008 Nov; 168(21):2311-6. PubMed ID: 19029493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland.
    Anttila A; Koskela J; Hakama M
    J Med Screen; 2002; 9(4):153-8. PubMed ID: 12518004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower recurrence risk through mammographic screening reduces breast cancer treatment costs.
    Kauhava L; Immonen-Räihä P; Parvinen I; Holli K; Pylkkänen L; Kaljonen A; Helenius H; Kronqvist P; Klemi PJ
    Breast; 2008 Dec; 17(6):550-4. PubMed ID: 18922695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammography screening in the county of Fyn. November 1993-December 1999.
    Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
    APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
    Hendrick RE
    Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-view versus single-view mammography at subsequent screening in a region of the Dutch breast screening programme.
    van Breest Smallenburg V; Duijm LE; den Heeten GJ; Groenewoud JH; Jansen FH; Fracheboud J; Plaisier ML; van Doorne-Nagtegaal HJ; Broeders MJ
    Eur J Radiol; 2012 Sep; 81(9):2189-94. PubMed ID: 21906898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women.
    Barfar E; Rashidian A; Hosseini H; Nosratnejad S; Barooti E; Zendehdel K
    Arch Iran Med; 2014 Apr; 17(4):241-5. PubMed ID: 24724599
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.